Page last updated: 2024-11-07

spironolactone and Muscular Dystrophy

spironolactone has been researched along with Muscular Dystrophy in 3 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research Excerpts

ExcerptRelevanceReference
" Combined treatment with the ACEi lisinopril and the nonspecific MR antagonist spironolactone surprisingly improves skeletal muscle, in addition to heart function and pathology in a Duchenne muscular dystrophy (DMD) mouse model."3.85Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles. ( Bhattacharya, S; Chadwick, JA; Lowe, J; Rafael-Fortney, JA; Weisleder, N, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chadwick, JA1
Bhattacharya, S1
Lowe, J1
Weisleder, N1
Rafael-Fortney, JA1
PEARSON, CM1
Nielsen, H1
Landbo, K1

Other Studies

3 other studies available for spironolactone and Muscular Dystrophy

ArticleYear
Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.
    American journal of physiology. Cell physiology, 2017, Feb-01, Volume: 312, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Membrane; Dose-Response Relationship, Drug;

2017
THE PERIODIC PARALYSES: DIFFERENTIAL FEATURES AND PATHOLOGICAL OBSERVATIONS IN PERMANENT MYOPATHIC WEAKNESS.
    Brain : a journal of neurology, 1964, Volume: 87

    Topics: Acetazolamide; Drug Therapy; Epinephrine; Humans; Hydrochlorothiazide; Hydrocortisone; Hyperkalemia;

1964
[Hypokalemia, myopathy with myoglobinuria after prolonged ingestion of licorice].
    Ugeskrift for laeger, 1970, Sep-17, Volume: 132, Issue:38

    Topics: Adult; Alkalosis; Glycyrrhiza; Humans; Hypokalemia; Male; Muscular Dystrophies; Myoglobinuria; Plant

1970